[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX2015013365A - Derivados de urea y su uso como inhibidores de proteina de union de acidos grasos (puag). - Google Patents

Derivados de urea y su uso como inhibidores de proteina de union de acidos grasos (puag).

Info

Publication number
MX2015013365A
MX2015013365A MX2015013365A MX2015013365A MX2015013365A MX 2015013365 A MX2015013365 A MX 2015013365A MX 2015013365 A MX2015013365 A MX 2015013365A MX 2015013365 A MX2015013365 A MX 2015013365A MX 2015013365 A MX2015013365 A MX 2015013365A
Authority
MX
Mexico
Prior art keywords
fabp
inhibitors
fatty
binding protein
acid binding
Prior art date
Application number
MX2015013365A
Other languages
English (en)
Inventor
Werner Neidhart
Aurelia Conte
Bernd Kuhn
Simona M Ceccarelli
Ulrike Obst Sander
Hans Richter
Holger Kuehne
Bernd Buettelmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2015013365A publication Critical patent/MX2015013365A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • C07C273/1854—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas by reactions not involving the formation of the N-C(O)-N- moiety
    • C07C273/1863—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas by reactions not involving the formation of the N-C(O)-N- moiety from urea
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5302—Apparatus specially adapted for immunological test procedures
    • G01N33/5304—Reaction vessels, e.g. agglutination plates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención proporciona nuevos compuestos de fórmula general (I) en done R1, R2, R3, R4, W, A y B son tal como se indica en el presente documento, composiciones que incluyen los compuestos y métodos de utilización de los compuestos.
MX2015013365A 2013-03-20 2014-03-17 Derivados de urea y su uso como inhibidores de proteina de union de acidos grasos (puag). MX2015013365A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13160088 2013-03-20
PCT/EP2014/055224 WO2014146995A1 (en) 2013-03-20 2014-03-17 Urea derivatives and their use as fatty-acid binding protein (fabp) inhibitors

Publications (1)

Publication Number Publication Date
MX2015013365A true MX2015013365A (es) 2016-01-08

Family

ID=47900931

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015013365A MX2015013365A (es) 2013-03-20 2014-03-17 Derivados de urea y su uso como inhibidores de proteina de union de acidos grasos (puag).

Country Status (13)

Country Link
US (1) US9278918B2 (es)
EP (1) EP2991967A1 (es)
JP (1) JP6235048B2 (es)
KR (1) KR101804650B1 (es)
CN (1) CN105308020B (es)
AR (1) AR095570A1 (es)
BR (1) BR112015024109A2 (es)
CA (1) CA2898534C (es)
HK (1) HK1214238A1 (es)
MX (1) MX2015013365A (es)
RU (1) RU2642454C2 (es)
TW (1) TWI629258B (es)
WO (1) WO2014146995A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017007755A1 (en) 2015-07-06 2017-01-12 Rodin Therapeutics, Inc. Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
HUE057041T2 (hu) 2015-07-06 2022-04-28 Alkermes Inc Hiszton deacetiláz hetero-halogén gátlói
WO2018066646A1 (ja) 2016-10-06 2018-04-12 第一三共株式会社 尿素誘導体
HRP20220223T1 (hr) 2017-01-11 2022-04-29 Alkermes, Inc. Biciklički inhibitori histon deacetilaze
EA039417B1 (ru) 2017-08-07 2022-01-25 Родин Терапеутикс, Инк. Бициклические ингибиторы гистондеацетилазы
CN113401281B (zh) * 2021-08-17 2021-11-02 南通御美津精密工业有限公司 一种船体锚穴外板开口用的关闭装置
AU2022345018A1 (en) * 2021-09-15 2024-03-28 Celloram, Inc. Fabp4/5 inhibitors, methods of use and methods of making

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3382406D1 (de) * 1982-04-08 1991-10-17 Shell Int Research Neue hydantoine, ihre herstellung und verwendung.
IL135176A0 (en) * 1997-11-10 2001-05-20 Bristol Myers Squibb Co Benzothiazole derivatives and pharmaceutical compositions containing the same
US6727247B2 (en) * 2001-12-10 2004-04-27 Hoffman-La Roche Inc. Substituted benzothiazole amide derivatives
EP1554240B1 (en) * 2002-10-21 2009-05-06 Janssen Pharmaceutica N.V. Substituted tetralins and indanes and their use
WO2005044810A1 (en) 2003-10-30 2005-05-19 Janssen Pharmaceutica, N.V. Glyt2 modulators
FR2869903B1 (fr) * 2004-05-06 2006-06-23 Galderma Res & Dev Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppary, leur procede de preparation et leur utilisation dans les compositions cosmetiques ou pharmaceutiques
JP4047365B2 (ja) * 2006-01-11 2008-02-13 生化学工業株式会社 シクロアルカンカルボキサミド誘導体及びその製造方法
EP2040690B1 (en) * 2006-06-28 2014-08-06 Sanofi Inhibitors of cxcr2
WO2008092878A1 (en) * 2007-02-01 2008-08-07 Glaxo Group Limited Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
WO2009034062A1 (en) * 2007-09-11 2009-03-19 Glaxo Group Limited Compounds which inhibit the glycine transporter and uses thereof in medicine
US8815875B2 (en) * 2008-11-12 2014-08-26 Merck Sharp & Dohme Corp. Inhibitors of fatty acid binding protein (FABP)

Also Published As

Publication number Publication date
CA2898534C (en) 2017-09-19
WO2014146995A1 (en) 2014-09-25
JP2016514106A (ja) 2016-05-19
AR095570A1 (es) 2015-10-28
EP2991967A1 (en) 2016-03-09
CN105308020B (zh) 2018-01-26
HK1214238A1 (zh) 2016-07-22
BR112015024109A2 (pt) 2017-07-18
CA2898534A1 (en) 2014-09-25
KR101804650B1 (ko) 2018-01-10
TWI629258B (zh) 2018-07-11
JP6235048B2 (ja) 2017-11-22
RU2015140599A (ru) 2017-04-26
US9278918B2 (en) 2016-03-08
RU2642454C2 (ru) 2018-01-25
TW201514138A (zh) 2015-04-16
US20160002152A1 (en) 2016-01-07
CN105308020A (zh) 2016-02-03
KR20150119357A (ko) 2015-10-23

Similar Documents

Publication Publication Date Title
PH12017502090A1 (en) Heterocyclic amides as kinase inhibitors
EA201591497A1 (ru) Новые производные октагидропирроло[3,4-c]пиррола и их аналоги в качестве ингибиторов аутотаксина
PH12015500263A1 (en) New bicyclic derivatives
PH12014502697B1 (en) New diazaspirocycloalkane and azaspirocycloalkane
JO3515B1 (ar) مثبطات fgfr4 بيريميدين
MX341456B (es) Amino-quinolinas como inhibidores de cinasa.
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
MY169267A (en) New aryl-quinoline derivatives
MX2014001879A (es) Aminoquinazolinas como inhibidores de quinasa.
MX2014014531A (es) Derivados de aminoquinazolina y piridopirimidina.
MX2015013365A (es) Derivados de urea y su uso como inhibidores de proteina de union de acidos grasos (puag).
PH12015500345A1 (en) Amino-quinolines as kinase inhibitors
MX2015017156A (es) Inhibidores de bace.
MX2014014708A (es) Nuevos compuestos biciclicos de tiofenilamida.
MX2015016332A (es) Inhibidores de alk biciclicos fusionados.
PH12015502462A1 (en) Imidazo-triazine derivatives as pde10 inhibitors
MX2015013374A (es) Derivados de urea y su uso como inhibidores de proteina de uniuon a acidos grasos (puag).
MX2013009388A (es) Nuevos compuestos de azaespirodecanona como inhibidores de lipasa sensible a hormonas (hsl).
MX2015011005A (es) Derivados de dihidorquinolin-2-ona para usarse como inhibidores de aldoesterona sintasa.
EA201590729A1 (ru) Производные 3,4-дизамещенного оксазолидинона и их применение в качестве ингибиторов кальцийактивируемых калиевых каналов
MX344429B (es) Nuevos compuestos de hexahidropirroloimidazolona.
MX2016002762A (es) Derivados de fenil-dihidropiridina como inhibidores de aldosterona sintasa.
MX2014008856A (es) Derivados de imidazolilcetona como inhibidores de aldosterona sintasa.

Legal Events

Date Code Title Description
FG Grant or registration